SHINE Technologies
Janesville
About SHINE Technologies
SHINE deploys its safe, cost-effective, and environmentally friendly fusion technology in a stepwise approach. Its systems are used to inspect industrial components in aerospace, defense, energy, and other sectors. SHINE’s proprietary medical isotope production processes create molybdenum-99 and non-carrier-added lutetium-177. These important medicines are used in tens of thousands of daily procedures to diagnose and treat heart disease, late-stage cancer, and other serious illnesses. In the future, SHINE plans to scale its fusion technology to help solve one of the energy’s toughest hurdles by recycling nuclear waste. Through a purpose-driven and phased approach, SHINE aims to generate fusion power to deliver clean, abundant energy that could transform life on Earth.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $1.0B
- Funding stage: Private Equity
- Last round: Private Equity (Feb 2026)
- Website: shinefusion.com
- Phone: (608) 210-1060
Industries & Categories
Biotechnology, Energy, Health Care, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/shine-technologies-112603 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.